Marshall Wace’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-134,503
Closed -$1.33M 4523
2021
Q3
$1.33M Buy
134,503
+20,619
+18% +$204K 0.01% 1823
2021
Q2
$1.12M Hold
113,884
0.01% 1759
2021
Q1
$1.14M Buy
+113,884
New +$1.17M 0.01% 1592

Marshall Wace's HCAQ Position: Q4 2021 in Review

Marshall Wace sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 134,503 shares — an estimated $1.33M sold.

Marshall Wace first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $1.33M in Q3 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

  • Marshall Wace reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 134,503 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $1.33M.
  • Marshall Wace first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • Marshall Wace's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $1.33M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.